RxSight (RXST) Change in Cash (2020 - 2026)

RxSight (RXST) has reported Change in Cash for 7 consecutive years, with -$4.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash fell 134.16% year-over-year to -$4.2 million; the trailing twelve-month figure through Jun 2026 stood at -$27.0 million (down 269.32% YoY), and the FY2025 full-year result was $3.2 million, down 54.02% from the prior year.
• Change in Cash declined to -$4.2 million in Q2 2026 per RXST's latest filing, from -$2.4 million in the prior quarter.
• Across five years, Change in Cash topped out at $23.0 million in Q1 2024 and bottomed at -$15.1 million in Q3 2022.
• Historically, Change in Cash has averaged -$615000.0 across 5 years, with a median of -$525500.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Change in Cash surged 2892.46% in 2024, then tumbled 40445.83% in 2025.
• Over 5 years, Change in Cash stood at $2.9 million in 2022, then plunged by 105.78% to -$166000.0 in 2023, then jumped by 114.46% to $24000.0 in 2024, then sank by 40445.83% to -$9.7 million in 2025, then jumped by 56.41% to -$4.2 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$4.2 million, -$2.4 million, and -$9.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.